We observed no significant correlations between IDO1, IDO2, TDO2, and IL4I1 expression and clinical characteristics of patients with DLBCL or NK/TCL (Tables 1 and 2). The gene discussed is TDO2; the disease is diffuse large B-cell lymphoma.